title: [Treatment effectiveness of hypertension during pregnancy].
abstract: OBJECTIVE
  To compare the maternal-fetal clinical intercurrences and the effectiveness of treatment in the different clinical forms of hypertensive syndromes during pregnancy (HSP).
  
  
  METHODS
  Medical records of 200 pregnant women with HSP were reviewed to appraise fetal intercurrences, classification of the hypertensive syndrome and use of antihypertensives.
  
  
  RESULTS
  Of the 200 patients analyzed, 85 (42.5%) were controls; 32 (16%) presented gestational hypertension (GH), 67 (33.5%) had Pre-eclampsia (PE), 6 (3%) had chronic hypertension and 10 (5%) cases had PE superimposed chronic hypertension (PSCH). The lowest values for gestational age, weights of the newborn and for the Apgar index were observed in the patients with PE and PSCH. Treatment did not alter the Apgar index in relation to control and non-treated GH patients. Patients with PE presented the lowest gestational age and the smallest Apgar index when compared to controls.
  
  
  CONCLUSIONS
  Introduction of an antihypertensive therapy during gestation was of fundamental importance for health improvement and pressure control of the pregnant woman with HSP. Nevertheless, it has been of little help for prevention of perinatal intercurrences. This was substantiated by the absence of improvement in the gestational conditions between the treated group when compared to the non-treated. Medication did not significantly improve the maternal-fetal blood flow and consequently in the birth condition of the child.
authors.affiliation: Departamento de Ciências Biológicas, Universidade Federal do Triângulo Mineiro, Avenida Frei Paulino no. 30, Bairro Abadia, 38025-180 Uberaba, Minas Gerais.
authors.forename: Mauro Henrique de Lima
authors.initials: MH
authors.lastname: Ferrão
authors.forename: Ana Carolina Lúcio
authors.initials: AC
authors.lastname: Pereira
authors.forename: Heloísa Cristina Torres Soares
authors.initials: HC
authors.lastname: Gersgorin
authors.forename: Thales Antônio Abra de
authors.initials: TA
authors.lastname: Paula
authors.forename: Rosana Rosa Miranda
authors.initials: RR
authors.lastname: Corrêa
authors.forename: Eumenia Costa da Cunha
authors.initials: EC
authors.lastname: Castro
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001724:Birth Weight; D016022:Case-Control Studies; D002908:Chronic Disease; D005260:Female; D005865:Gestational Age; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D046110:Hypertension, Pregnancy-Induced / Q000175:diagnosis / Q000188:drug therapy*; D007231:Infant, Newborn; D008750:Methyldopa / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000175:diagnosis; D011247:Pregnancy; D011256:Pregnancy Outcome; D012307:Risk Factors; D018709:Statistics, Nonparametric; D013577:Syndrome
chemical_list: D000959:Antihypertensive Agents; D006830:Hydralazine; D008750:Methyldopa